Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combigan for IOP Prophylaxis After Anti-VEGF Injection
NCT02623023Withdrawn
- Sponsor
- McMaster University
- Start
- Jan 2019
- Primary completion
- Jan 2019
01
Overview
Randomised, double-blind trial of brimonidine tartrate + timolol maleate in ocular hypertension, sponsored by McMaster University. Primary endpoint: Intraocular Pressure at 6 months. Planned start Jan 2019; status: withdrawn.
02
Drugs
brimonidine tartrate + timolol maleate
03
Conditions
ocular hypertension
Beyond the preview
Go deeper on NCT02623023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02623023.